C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries.

نویسندگان

  • J Torzewski
  • M Torzewski
  • D E Bowyer
  • M Fröhlich
  • W Koenig
  • J Waltenberger
  • C Fitzsimmons
  • V Hombach
چکیده

There is increasing evidence that complement activation may play a role in atherogenesis. Complement proteins have been demonstrated to be present in early atherosclerotic lesions of animals and humans, and cholesterol-induced atherosclerotic lesion formation is reduced in complement-deficient animals. Potential complement activators in atherosclerotic lesions are now a subject matter of debate. C-reactive protein (CRP) is an acute-phase protein that is involved in inflammatory processes in numerous ways. It binds to lipoproteins and activates the complement system via the classic pathway. In this study we have investigated early atherosclerotic lesions of human coronary arteries by means of immunohistochemical staining. We demonstrate here that CRP deposits in the arterial wall in early atherosclerotic lesions with 2 predominant manifestations. First, there is a diffuse rather than a focal deposition in the deep fibroelastic layer and in the fibromuscular layer of the intima adjacent to the media. In this location, CRP frequently colocalizes with the terminal complement complex. Second, the majority of foam cells below the endothelium show positive staining for CRP. In this location, no colocalization with the terminal complement proteins can be observed. Our data suggest that CRP may promote atherosclerotic lesion formation by activating the complement system and being involved in foam cell formation.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Association of complement inhibitors with connective tissue matrix in atherosclerotic lesions.

Connective Tissue Matrix in Atherosclerotic Lesions To the Editor: We read with great interest the article by Oksjoki et al1 regarding association between complement Factor H and proteoglycans in early human coronary atherosclerotic lesions. We would like to add several comments to this recently published article. Several studies have demonstrated the presence of terminal complement complex C5b...

متن کامل

Evidence that macrophages in atherosclerotic lesions contain angiotensin II.

BACKGROUND We have reported that human mononuclear leukocytes contain large amounts of angiotensin II (Ang II). The goal of the present study was to test the hypothesis that Ang II is present in monocyte/macrophages in atherosclerotic lesions. METHODS AND RESULTS Segments of thoracic aorta and left circumflex coronary artery were obtained from 3 groups of cynomolgus monkeys: normal, atheroscl...

متن کامل

Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation.

Complement activation occurs in temporal correlation with the subendothelial deposition of LDL during early atherogenesis, and complement also plays a pathogenetic role in promoting lesion progression. Two lesion components have been identified that may be responsible for complement activation. First, enzymatic degradation of LDL generates a derivative that can spontaneously activate complement...

متن کامل

Potential Mechanisms of Mast Cell Activation in Human Atherosclerotic Coronary Arteries

Background Mast cells are cells filled with cytoplasmic secretory granules and are found in both the adventitia and the intima of human coronary arteries. The mast cell granules contain vasoactive substances (notably histamine), proteolytic enzymes, cytokines, growth factors, and proteoglycans. To exert pathophysiological effects in tissues, mast cells need to become activated and secrete their...

متن کامل

Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation.

OBJECTIVE Complement activation has been suggested to play a role in atherogenesis. To study the regulation of complement activation in human coronary atherosclerotic lesions, we examined the spatial relationships between the major complement inhibitor, factor H, and the complement activation products C3d and C5b-9. METHODS AND RESULTS In early lesions (American Heart Association types II and...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Arteriosclerosis, thrombosis, and vascular biology

دوره 18 9  شماره 

صفحات  -

تاریخ انتشار 1998